| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/27/1997 | US5632984 Method of treatment of macular degeneration |
| 05/27/1997 | US5632983 Method for treating secondary immunodeficiency |
| 05/27/1997 | US5632982 Cytotoxic enhancement of TNF with copper |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/27/1997 | CA1339047C Production of erythropoietin |
| 05/22/1997 | WO1997018332A1 Regulation of cancer-causing tyrosine kinases by potassium ion conductance |
| 05/22/1997 | WO1997018319A1 Joint expression of gtp cyclohydrolase and tyrosine hydroxylase |
| 05/22/1997 | WO1997018315A1 Hybrid factor viii with modified activity |
| 05/22/1997 | WO1997018312A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | WO1997018309A1 E6 binding proteins |
| 05/22/1997 | WO1997018308A2 K-atp channel protein and methods relating to it |
| 05/22/1997 | WO1997018307A1 Fas ligand fusion protein |
| 05/22/1997 | WO1997018304A1 Methods for modulation of cholesterol transport |
| 05/22/1997 | WO1997018303A1 Rac-proteine kinase as therapeutic agent or in diagnostics |
| 05/22/1997 | WO1997018301A1 Synthetic hpv11 virus-like particles |
| 05/22/1997 | WO1997018241A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | WO1997018239A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 05/22/1997 | WO1997018238A2 Crf analogs |
| 05/22/1997 | WO1997018237A1 Chemokine from niddm pancreas |
| 05/22/1997 | WO1997018236A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
| 05/22/1997 | WO1997018235A1 Peptide conjugates, use thereof as a drug, and compositions containing same |
| 05/22/1997 | WO1997018232A2 Peptides derived from the oncogene proteine bcr-abl expressed by leukemic cells and utilisation thereof for the therapy of human leukemiae |
| 05/22/1997 | WO1997018230A1 Cloning and expression of beta app-c100 receptor (c100-r) |
| 05/22/1997 | WO1997018229A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | WO1997018228A1 The transcriptional promoter of the obesity gene |
| 05/22/1997 | WO1997018225A1 Salmonella secreted proteins and uses thereof |
| 05/22/1997 | WO1997018224A1 Human stem cell antigen 2 |
| 05/22/1997 | WO1997018223A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | WO1997018207A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 05/22/1997 | WO1997018185A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 05/22/1997 | WO1997017994A1 Treatment of diabetes with a glucokinase gene |
| 05/22/1997 | WO1997017991A1 Remedy for acute hepatic insufficiency |
| 05/22/1997 | WO1997017990A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 05/22/1997 | WO1997017989A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 05/22/1997 | WO1997017988A1 Type ix collagen and chimeras |
| 05/22/1997 | WO1997017987A1 C9 complement inhibitor |
| 05/22/1997 | WO1997017986A1 Nima interacting proteins |
| 05/22/1997 | WO1997017985A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017984A1 Oligodendrocyte-specific protein and method for treating disease |
| 05/22/1997 | WO1997017983A1 Methods of treating disorders of non-visual sensory epithelia |
| 05/22/1997 | WO1997017982A1 Methods and compositions for hair growth promotion |
| 05/22/1997 | WO1997017980A1 Treatment of cardiomyopathy by removal of autoantibodies |
| 05/22/1997 | WO1997017966A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017945A2 Methods and compositions for the delivery of monomeric proteins |
| 05/22/1997 | WO1997012961A3 Growth of adult pancreatic islet cells with laminin 5 |
| 05/22/1997 | WO1997009344A3 Librairies of backbone-cyclized peptidomimetics |
| 05/22/1997 | WO1997008314A3 Telomere repeat binding factor and diagnostic and therapeutic use thereof |
| 05/22/1997 | WO1997007213A3 Assay for identifying genes causing chromosome non-disjunction |
| 05/22/1997 | WO1997007135A3 Binding of osteogenic protein-i (op-1) and analogs thereof to the cell surface receptor alk-1 and analogs thereof |
| 05/22/1997 | WO1997005252A3 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
| 05/22/1997 | WO1997002004A3 Methods for treating diabetes |
| 05/22/1997 | DE19544167A1 Verwendung von Interferon-ß zur Behandlung von Bronchialkarzinom bei Bestrahlungstherapie Use of beta-interferon for the treatment of lung cancer with radiation therapy |
| 05/22/1997 | DE19542837A1 Formulation contg. microparticles of polymer matrix contg. active agent |
| 05/22/1997 | CA2240192A1 Methods for screening compounds that modulate cholesterol transport |
| 05/22/1997 | CA2238007A1 Cloning and expression of .beta.app-c100 receptor (c100-r) |
| 05/22/1997 | CA2237998A1 Chemokine from niddm pancreas |
| 05/22/1997 | CA2237993A1 Peptide conjugates, use thereof as a drug, and compositions containing same |
| 05/22/1997 | CA2237900A1 Type ix collagen and chimeras |
| 05/22/1997 | CA2237818A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 05/22/1997 | CA2237783A1 E6 binding proteins |
| 05/22/1997 | CA2237581A1 Salmonella secreted proteins and uses thereof |
| 05/22/1997 | CA2237565A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | CA2237528A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | CA2237524A1 Novel macrocyclic compounds as metalloprotease inhibitors |
| 05/22/1997 | CA2237400A1 Methods of treating disorders of non-visual sensory epithelia |
| 05/22/1997 | CA2236332A1 Treatment of diabetes with a glucokinase gene |
| 05/22/1997 | CA2236076A1 The transcriptional promoter of the obesity gene |
| 05/22/1997 | CA2235695A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 05/22/1997 | CA2235628A1 Hybrid factor viii with modified activity |
| 05/22/1997 | CA2234661A1 Mimotopes and anti-mimotopes of human platelet glycoprotein ib/ix |
| 05/22/1997 | CA2232876A1 Fas ligand fusion protein |
| 05/21/1997 | EP0774261A2 Uses of von Willebrand Factor and pharmaceutical preparations |
| 05/21/1997 | EP0774260A1 Remedy for corneal diseases |
| 05/21/1997 | EP0774252A1 Cytokine potentiator and remedy for diseases wherein cytokine activity is reduced |
| 05/21/1997 | EP0774250A1 Use of a TNF alpha antagonist against skin redness of neurogenic origin |
| 05/21/1997 | EP0774008A1 Adenovirus including a gene coding for a superoxide dismutase |
| 05/21/1997 | EP0774005A1 Surface expression of enzyme in gene directed prodrug therapy |
| 05/21/1997 | EP0774004A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 05/21/1997 | EP0774003A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 05/21/1997 | EP0774001A1 Production of tissue factor pathway inhibitor |
| 05/21/1997 | EP0774000A1 Antibodies that bind a conformationally altered cd4 molecule induced upon human immunodefficiency virus binding |
| 05/21/1997 | EP0773999A2 Or-1 on orphan receptor belonging to the nuclear receptor family |
| 05/21/1997 | EP0773998A1 Novel vesicular acetylcholine carrier |
| 05/21/1997 | EP0773997A2 Htk ligand |
| 05/21/1997 | EP0773996A1 INTERRUPTION OF BINDING OF MDM2 AND p53 PROTEIN AND THERAPEUTIC APPLICATION THEREOF |
| 05/21/1997 | EP0773995A1 Dna encoding the vertebrate homolog of hedgehog, vhh-1, expressed by the notochord, and uses thereof |
| 05/21/1997 | EP0773994A1 Receptor-ligand assay |
| 05/21/1997 | EP0773993A1 Genetically engineered swine cells |
| 05/21/1997 | EP0773992A1 Transgenically produced antithrombin iii |
| 05/21/1997 | EP0773962A1 Antibodies which activate an erythropoietin receptor |
| 05/21/1997 | EP0773960A1 POLYPEPTIDES WITH Fc BINDING ABILITY |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773958A1 PTH OR PTHrP ANTAGONISTS |
| 05/21/1997 | EP0773956A1 Purified form of streptogramines, preparation of same and pharmaceutical compositions containing same |
| 05/21/1997 | EP0773955A1 New thrombin inhibitors, their preparation and use |
| 05/21/1997 | EP0773950A1 Linked peptide nucleic acids |
| 05/21/1997 | EP0773793A1 Treatment of autoimmune diseases |
| 05/21/1997 | EP0773792A1 Combination treatment as animal growth promoter containing bovine somatotropin and an estrogenic agent |
| 05/21/1997 | EP0773791A1 Drug delivery composition for the nasal administration of antiviral agents |